|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/15/20 BioCorRx Inc. 10-Q 3/31/20 83:3.7M Discount Edgar/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 403K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 27K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 27K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 21K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 21K
80: R1 Document and Entity Information HTML 50K
32: R2 Condensed Consolidated Balance Sheets HTML 123K
25: R3 Condensed Consolidated Balance Sheets HTML 52K
(Parenthetical)
49: R4 Condensed Consolidated Statements of Operations HTML 73K
(Unaudited)
79: R5 Condensed Consolidated Statement of Equity HTML 60K
(Unaudited)
30: R6 Condensed Consolidated Statements of Cash Flows HTML 98K
(Unaudited)
23: R7 Business HTML 27K
51: R8 Significant Accounting Policies HTML 72K
77: R9 Going Concern and Management's Liquidity Plans HTML 28K
22: R10 Prepaid Expenses HTML 28K
34: R11 Property and Equipment HTML 31K
78: R12 Leases HTML 37K
52: R13 Intellectual Property Licensing Rights HTML 33K
20: R14 Accounts Payable and Accrued Expenses HTML 30K
33: R15 Notes Payable HTML 25K
76: R16 Convertible Notes Payable HTML 25K
50: R17 Notes Payable-Related Parties HTML 28K
24: R18 Royalty Obligations, Net HTML 28K
31: R19 Stockholders' Equity (Deficit) HTML 31K
72: R20 Stock Options and Warrants HTML 61K
63: R21 Related Party Transactions HTML 34K
19: R22 Concentrations HTML 26K
45: R23 Non Controlling Interest HTML 32K
71: R24 Commitments and Contingencies HTML 44K
62: R25 Subsequent Events HTML 25K
18: R26 Significant Accounting Policies (Policies) HTML 124K
44: R27 Significant Accounting Policies (Tables) HTML 39K
70: R28 Prepaid Expenses (Tables) HTML 27K
64: R29 Property and Equipment (Tables) HTML 30K
47: R30 Leases (Tables) HTML 35K
73: R31 Intellectual Property Licensing Rights (Tables) HTML 30K
35: R32 Accounts Payable and Accrued Expenses (Tables) HTML 29K
26: R33 Stock Options and Warrants (Tables) HTML 53K
48: R34 Non Controlling Interest (Tables) HTML 33K
74: R35 Business (Details Narrative) HTML 32K
36: R36 Significant Accounting Policies (Details) HTML 30K
27: R37 Significant Accounting Policies (Details 1) HTML 29K
46: R38 Significant Accounting Policies (Details 2) HTML 30K
75: R39 Significant Accounting Policies (Details HTML 55K
Narrative)
60: R40 Going Concern and Management's Liquidity Plans HTML 30K
(Details Narrative)
67: R41 Prepaid Expenses (Details) HTML 34K
39: R42 Property and Equipment (Details) HTML 37K
12: R43 Property and Equipment (Details Narrative) HTML 24K
61: R44 Leases (Details) HTML 26K
68: R45 Leases (Details 1) HTML 35K
40: R46 Leases (Details 2) HTML 29K
13: R47 Leases (Details 3) HTML 26K
59: R48 Leases (Details Narrative) HTML 45K
69: R49 Intellectual Property Licensing Rights (Details) HTML 31K
83: R50 Intellectual Property Licensing Rights (Details 1) HTML 35K
54: R51 Intellectual Property Licensing Rights (Details HTML 40K
Narrative)
29: R52 Accounts Payable and Accrued Expenses (Details) HTML 34K
38: R53 Notes Payable (Details Narrative) HTML 29K
82: R54 Convertible Notes Payable (Details Narrative) HTML 26K
53: R55 Notes Payable-Related Parties (Details Narrative) HTML 51K
28: R56 Royalty Obligations Net (Details Narrative) HTML 25K
37: R57 Stockholders' Equity (Deficit) (Details Narrative) HTML 69K
81: R58 Stock Options and Warrants (Details) HTML 59K
55: R59 Stock Options and Warrants (Details 1) HTML 39K
16: R60 Stock Options and Warrants (Details 2) HTML 44K
43: R61 Stock Options and Warrants (Details 3) HTML 46K
66: R62 Stock Options and Warrants (Details Narrative) HTML 52K
57: R63 Related Party Transactions (Details Narrative) HTML 68K
15: R64 Concentrations (Details Narrative) HTML 36K
42: R65 Non Controlling Interest (Details) HTML 26K
65: R66 Non Controlling Interest (Details 1) HTML 26K
56: R67 Non Controlling Interest (Details Narrative) HTML 25K
17: R68 Commitments and Contingencies (Details Narrative) HTML 95K
41: R69 Subsequent Events (Details Narrative) HTML 31K
58: XML IDEA XML File -- Filing Summary XML 150K
14: EXCEL IDEA Workbook of Financial Reports XLSX 85K
6: EX-101.INS XBRL Instance -- bicx-20200331 XML 972K
9: EX-101.CAL XBRL Calculations -- bicx-20200331_cal XML 77K
11: EX-101.DEF XBRL Definitions -- bicx-20200331_def XML 568K
8: EX-101.LAB XBRL Labels -- bicx-20200331_lab XML 947K
10: EX-101.PRE XBRL Presentations -- bicx-20200331_pre XML 787K
7: EX-101.SCH XBRL Schema -- bicx-20200331 XSD 261K
21: ZIP XBRL Zipped Folder -- 0001477932-20-002718-xbrl Zip 128K
EXHIBIT 32.1
CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Brady Grainer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of BioCorRx Inc. on Form 10-Q for the quarter ended March 31, 2020 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in this Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of BioCorRx Inc.
| Date: May 15, 2020 | By: | /s/ Brady Grainer | |
|
| |||
|
| Chief Executive Officer |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 5/15/20 | |||
| For Period end: | 3/31/20 | 4 | ||
| List all Filings | ||||